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Abstract
Background—Previous analyses identified specific geographic areas in Philadelphia (hotspots) 
associated with negative outcomes along the HIV care continuum. We examined individual and 
community factors associated with residing in these hotspots.
Methods—Retrospective cohort of 1,404 persons newly diagnosed with HIV in 2008–2009 
followed for 24 months after linkage to care. Multivariable regression examined associations 
between individual (age, sex, race/ethnicity, HIV transmission risk, and insurance status) and 
community (economic deprivation, distance to care, access to public transit, and access to 
pharmacy services) factors and the outcomes: residence in a hotspot associated with poor retention 
in care and residence in a hotspot associated with poor viral suppression.
Results—24.4% and 13.7% of persons resided in hotspots associated with poor retention and 
poor viral suppression, respectively. For persons residing in poor retention hotspots, 28.3% were 
retained in care compared to 40.4% of those residing outside hotspots (p<0.05). Similarly, for 
persons residing in poor viral suppression hotspots, 51.4% achieved viral suppression compared to 
75.3% of those outside hotspots (p<.0.05). Factors significantly associated with residence in a 
poor retention hotspots included: female sex, lower economic deprivation, greater access to public 
transit, shorter distance to medical care, and longer distance to pharmacies. Factors significantly 
associated with residence in a poor viral suppression hotspots included; female sex, higher 
economic deprivation, and shorter distance to pharmacies.
Conclusions—Individual and community-level associations with geographic hotspots may 
inform both content and delivery strategies for interventions designed to improve retention in care 
and viral suppression.
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INTRODUCTION
The HIV care continuum identifies distinct points for intervention, with the ultimate goal of 
improving health outcomes for people with HIV infection and reducing HIV transmission in 
the community.1 Prior studies indicate that linkage to care, retention in care, and viral 
suppression are influenced by a variety of individual, health system, and community-level 
factors.2–10 While linkage to care represents the entry point for HIV disease management, 
retention in care and sustained viral suppression are necessary to achieve the individual and 
public health benefits of HIV treatment.3,11 As monitoring of HIV infection increasingly 
focuses on the HIV care continuum11–14, analyses of public health surveillance data may 
reveal geographic patterns that vary at each step.15,16 Moreover, a better understanding of 
the structural and community-level factors that influence or impede completion of HIV care 
continuum steps is needed17–23.
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In prior work, we identified geographic areas in Philadelphia, PA with significantly higher 
concentrations of individuals with poor retention in care and poor viral suppression15. In 
total, 14 census tracts were associated with poor retention in care (3.7% of all census tracts 
in Philadelphia) and 12 census tracts were associated with poor viral suppression (3.2% of 
all census tracts in Philadelphia). Interestingly, the geographic areas identified for poor 
retention in care and poor viral suppression were unique, with no geographic overlap. This 
suggested that distinct community-level factors might be responsible for these poor 
outcomes. The current analyses build on prior work and aim to identify individual and 
community-level factors associated with residing in hotspots of poor retention in care and 
residing in hotspots of poor viral suppression in hopes of informing the development of 
interventions to improve the final steps of the HIV care continuum.
METHODS
Data Source & Study Population
Data were extracted from the City of Philadelphia’s Enhanced HIV/AIDS Reporting System 
(eHARS), a database containing information on all HIV cases reported to the Philadelphia 
Department of Public Health (PDPH) AIDS Activities Coordinating Office Surveillance 
Unit. Philadelphia has mandatory name-based case reporting of all new HIV infections. 
Additionally, local mandates require reporting of all CD4 cell counts <350/mL (or CD4 
percent <25%) and all HIV-1 RNA levels to the PDPH. Thus, eHARS contains records and 
laboratory results of all people living with HIV (PLWH) who were diagnosed with HIV in 
Philadelphia, were a resident of Philadelphia at any time after their HIV diagnosis, and all 
PLWH who received care in Philadelphia after their HIV diagnosis.
The eHARS database contains information collected through medical record abstraction 
including identifiers, such as name, address, date of birth, and address at diagnosis, as well 
as laboratory results which are received electronically and imported into the database. Death 
data from the Pennsylvania Bureau of Vital Statistics, Social Security Death Master Index, 
and the National Death Index are routinely matched to eHARS data to identify deceased 
persons and document cause of death when available. The eHARS data are routinely 
monitored to identify duplicate cases and undergo quality control and verification to ensure 
that abstracted data are correctly assigned to unique case records.
Because the current analyses rely on exact identification of case locations and focus on 
patients successfully linked to care, individuals were included if they had a: (1) HIV 
diagnosis date in 2008 or 2009, (2) Philadelphia address at time of diagnosis, and (3) were 
successfully linked to care, defined as documentation of 1 or more CD4 or viral load test 
results after the date of diagnosis. Those with invalid or insufficient address data, along with 
persons with only a correctional facility address at time of diagnosis, were excluded from 
analyses (N=157). Cases were followed for 24 months after linkage to care.
The time period of 2008 to 2009 was selected to further define factors associated with poor 
retention in care and poor viral suppression and to allow for a 24-month interval for 
observation, as described below.
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Outcome Variables
Previous analyses of this cohort identified geographic areas of the city where patients with 
negative outcomes (not retained in care, not virally suppressed) exhibited significant 
clustering compared to the cohort as a whole.15 For these analyses, we used these previously 
identified areas to classify cases dichotomously as either in or near (within 5,000 feet) a 
significant hot-spot, or not in or near a significant hot-spot. Hot-spots were identified by 
calculating the local version of the cross K function, which uses a marked-point process to 
compare sub-groups and is described elsewhere.15 Figure 1 provides maps showing the 
locations of these hotspots.
Retention in care was defined using the National Quality Forum Medical Visit Frequency 
Measure24. This measure defines retention in care as completing at least 1 medical visit with 
a provider with prescribing privileges in each 6-month interval of the 24-month 
measurement period, with a minimum of 60 days between medical visits. Date of first 
linkage to care defined the start of the 24-month measurement period. We used laboratory 
reports of CD4 counts and/or viral load testing as a proxy for HIV medical care visits. 
Previous studies have shown high correlation between laboratory test and medical visit data 
and retention in care.25 Viral suppression was classified as evidence of HIV-1 RNA <200 
copies per milliliter closest to the end of the 24-month measurement period +/− 120 days. 
For the viral suppression analysis, we only included persons who met the retention in care 
definition so that we could look at predictors of viral suppression that are independent of 
retention in care.
Predictor Variables
Individual-Level Factors—For each person, we defined age, sex at birth, race/ethnicity, 
HIV transmission risk, and insurance status at the time of HIV diagnosis. Date of HIV 
diagnosis was defined as the date of collection of confirmatory test results. Age was 
categorized into three groups: <25, 25–44, and ≥45 years old. Race/ethnicity categories were 
divided into four groups: non-Hispanic white, non-Hispanic Black, Hispanic, and other. 
Transmission risk was grouped into heterosexual, men who had sex with men (MSM), 
injection drug use (IDU), and other/unknown. Patients who had IDU in combination with 
another risk factor (e.g., MSM, heterosexual transmission) were classified as IDU. Insurance 
status was classified as Medicaid, Medicare, private, no insurance, and other or unknown.
Community-Level Factors—Travel distance to medical care was assessed using the 
spatial locations of cases and HIV care providers. Cases were geocoded using the street 
address at time of HIV diagnosis. Medical care sites where initial linkage to care occurred 
were geocoded using the facility address. Distances were calculated (in miles) through 
network analysis using street-level data to calculate the distance required to travel from 
point A (residence) to point B (medical care) under normal driving conditions.
All pharmacies currently operating in Philadelphia were geocoded based on street address. 
The locations were assigned to census tracts using the 2010 decennial census tracts and 
summarized to calculate the total number of pharmacies in each tract. Pharmacy densities 
were calculated as the rate of pharmacy locations (per 1,000 population), using the 2010 
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population data from the U.S. Census Bureau. In addition, network analyses were conducted 
to determine the five closest pharmacies for each case using street-level data as the network 
dataset. Distances were calculated (in miles) using the “closest facility” function of the 
ArcGIS Network Analyst. Travel distance from point A (residence) to point B (pharmacy) 
was determined under normal driving conditions for the five closest pharmacies to each 
case, and an average distance was calculated for inclusion in the model.
Access to public transit was assessed by including data from a transit network dataset 
created from the General Transit Feed System (GTFS) provided by the Southeastern 
Pennsylvania Transit Authority (SEPTA) and tools developed by Environmental Systems 
Research Institute (ESRI)26. The SEPTA GTFS data includes all transit lines (buses, 
subways, and light rails) that serve Philadelphia, including the spatial locations of lines and 
stops, as well as schedule information. For this analysis we assigned census tracts to all 
SEPTA stops within Philadelphia, and summarized the data to calculate the rate (per 1,000 
population) of transit access in each tract.
Economic deprivation was assessed using a measure calculated from several components of 
the American Community Survey released by the U.S. Census Bureau. Data elements 
included in the index are: 1) percent employed in low-wage occupation; 2) percent 
households in poverty; 3) percent households receiving food stamps; 4) percent female-
headed households with dependent children; and 5) percent less than high school education. 
The percents of these five data elements were summed and averaged to created the 
deprivation score. For purposes of interpretation, a higher score indicates greater economic 
deprivation.
Statistical Analyses
Univariate statistics were used to describe the dataset. Multivariate logistic regression 
models were used to assess relationships between individual and community-level predictors 
and the two outcomes. Models were fitted using a forward stepwise logistic regression, with 
variables entered into the model based on a 0.05 significance level of the univariate chi-
square. Sex at birth, economic deprivation, public transit coverage, distance to medical care, 
and the average distance to the closest five pharmacies were included in model 1 (retention 
in care). Sex at birth, economic deprivation, and the average distance to the closest five 
pharmacies were included in model 2 (viral suppression). Adjusted odds ratios (AORs) with 
95% confidence intervals (CIs) are presented. Relationships were considered statistically 
significant at P <0.05. Analyses were conducted using SAS 9.2.
RESULTS
Demographics of the cohort are presented in Table 1. A total of 1,404 persons were 
diagnosed with HIV in 2008–2009, had a valid Philadelphia address at diagnosis, and 
successfully linked to HIV medical care. The population was predominantly male (69.6%), 
Black race/ethnicity (61.0%), between the ages of 25 and 44 at time of HIV diagnosis 
(47.2%) and had either MSM (38.3%) or heterosexual (40.5%) as their HIV risk factor. The 
mean deprivation score of the cohort was 19.33 indicating a higher degree of economic 
deprivation in our sample than the City of Philadelphia as a whole (15.66). The mean 
Eberhart et al. Page 5
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
pharmacy density was 0.35 pharmacies per 1,000 population, and mean public transit route 
density was 5.55 routes per 1,000 population. The mean distance to the facility of care was 
3.65 miles, while the mean distance to the five closest pharmacies was 0.56 miles.
Overall, among this cohort of patients linked to care, 37.5% were retained in care and 27.0% 
achieved viral suppression. In total, 24.4% of the sample resided in a poor retention hotspot 
and 13.7% in a poor viral suppression hotspot. Outcomes varied significantly by residence in 
a hotspot. For persons residing in a poor retention hotspot, 28.3% of cases were retained in 
care compared to 40.4% among those residing outside a poor retention hotspot (p<0.05). For 
those residing in a hotspot of poor viral suppression, 51.4% of those retained in care 
achieved viral suppression compared to 75.3% respectively for persons who did not reside in 
a poor retention hotspot (p<.0.05).
Associations with Residing in a Poor Retention Hotspot
As shown in Table 1, females were less likely to reside in geographic areas associated with 
poor retention in care (AOR = 0.63; 95% CI 0.45–0.88). Economic deprivation was 
inversely associated with residence in these areas (AOR = 0.92; 95% CI 0.90–0.94), 
indicating that as deprivation increased the probability of residing in a hotspot associated 
with poor retention decreased. The probability of residing in a hotspot for poor retention in 
care increased as the proportion of transit lines serving that area increased (AOR = 1.04; 
95% CI 1.00–1.09). In addition, residence in a hotspot for poor retention in care was 
associated with longer distance to the five nearest pharmacies (AOR = 2.41; 95% CI 1.14–
5.09), specifically as distance to a pharmacy increased the probability of residing in a 
hotspot increased. Travel distance to the location of HIV medical care was inversely 
associated with residence in a hotspot (AOR = 0.85; 95% CI 0.80–0.90), indicating that the 
probability of residing in a poor retention hotspot decreased as the distance traveled for care 
increased. Age, race/ethnicity, HIV transmission risk and insurance status were not 
significant in the univariate analyses and were therefore not included in the model.
Associations with Residing in Poor Viral Suppression Hotspots
As shown in Table 2, females were more likely to reside in hotspots associated with poor 
viral suppression (AOR = 1.74; 95% CI 1.00–3.01). Economic deprivation was significantly 
associated with residence in areas of poor viral suppression (AOR = 1.09; 95% CI 1.05–
1.12), indicating that as deprivation increased the probability of residing in one of these 
areas also increased. In contrast to the poor retention model, the average travel distance to 
the five closest pharmacies was inversely associated with residence in poor viral suppression 
hotspots (AOR = 0.12; 95% CI 0.02–0.70), indicating that the probability of residing in a 
hotspot decreased as distance to the 5 closest pharmacies increased. Age, sex, race/ethnicity, 
HIV transmission risk and insurance status were not significant in the univariate analyses 
and were therefore not included in the model.
DISCUSSION
In previous analyses, we identified hotspots of poor outcomes along the HIV care continuum 
for persons diagnosed with HIV in Philadelphia in 2008 and 2009. We found that for 
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individuals who resided in a hotspot, 54.3% of individuals diagnosed with HIV were linked 
to care, 24.0% retained in care, and 9.1% virally suppressed. In comparison, 64.6%, 33.0%, 
and 26.3% of individuals living outside of a hotspot were linked to care, retained in care, 
and virally suppressed, respectively. In multivariable regression models controlling for 
patient factors, residence in a hotspot was the only variable significantly associated with 
each of these outcomes. In this subsequent analysis of the same cohort, we found that 
community-level factors were more likely than individual-level characteristics to be 
associated with geographic clusters of both poor retention and poor viral suppression.
Interestingly, we identified different associations with residence in a hotspot for poor 
retention in care compared to residence in a hotspot of poor viral suppression - less 
economic depression versus greater economic depression, and longer distance to nearest 
pharmacies versus shorter distance to pharmacies respectively. These findings suggest that 
although retention in care and viral suppression are related, a unique set of factors influence 
each outcome. It is frequently assumed that persons not retained in HIV care are not on ART 
and therefore have detectable viral loads. However, recent studies indicate that persons on 
stable ART regimens complete fewer HIV medical visits than their counterparts, and thus 
may not meet standard definitions of retention in care27,28. Our analyses did not exclude 
persons who were virally suppressed from the retention in care model. Thus it is possible 
that our retention in care hotspot analysis may have captured a subset of individuals with 
well-controlled HIV infection despite less frequent medical visits. This may explain why 
persons residing in hotspots for poor retention in care were less likely to live in 
neighborhoods that were more economically depressed, had higher public transit coverage, 
and travelled shorter distance to HIV medical care. Qualitative data are needed to better 
understand the socioeconomic, clinical, and healthcare utilization characteristics of these 
individuals
Hotspots with poor viral suppression were more likely to be economically deprived and have 
a shorter average distance to the five nearest pharmacies. While personal income was not 
available in our dataset, economic deprivation of the census tract of residence was used as a 
proxy. The association between residence in a poor viral suppression hotspot and economic 
deprivation was consistent with prior literature, which describes poverty as a common factor 
associated with lower access to HIV care and treatment adherence.29–32 Residence in an 
area of higher economic deprivation may be a marker for personal economic deprivation, as 
well as other factors known to interfere with treatment adherence such as housing instability 
and food insecurity.33–35 Importantly, women were more likely to reside in hotspots for poor 
viral suppression than men. A number of prior studies have noted that women are less likely 
to achieve virally suppression.36–38 Our data suggests that after controlling for several 
community-level and individual-level characteristics, gender disparities remain. Further 
research is needed to better understand the influence of structural, behavioral, and biological 
factors on viral suppression among women.
In our analysis, residence in a hotspot for poor viral suppression was actually associated 
with a shorter distance to the nearest five pharmacies compared to residence in other areas. 
Previous studies have evaluated the relationship between distance to HIV medical care and 
access to healthcare noting that nearly half of PLWH travelled more than three miles farther 
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than the closest HIV care provider2,39. These findings indicate that selection of a medical 
provider is complex and that factors other than proximity influence this choice. Similar to 
the process of choosing a healthcare provider, selecting a pharmacy is influenced by 
multiple factors (e.g. preference of a particular company over another, hours of operation, 
proximity to other businesses, services offered such as onsite immunizations or pill box 
refills).40 A recent study evaluating the relationship between socio-economic status and 
access to prescription medications in New York City found that pharmacies in poor 
communities had a 24% increase in odds of medications being out of stock for each 10 
percentage-point increase in the number of households in poverty. Moreover, while the 
overall density of pharmacies in poor communities was greater than low-poverty 
communities, poor communities had (1) a higher density of small, independent pharmacies 
with limited stock and shorter hours of operation and (2) a lower density of large, chain 
pharmacies compared to low-poverty communities40. As a result, for PLWH living in 
economically deprived neighborhoods proximity to a pharmacy may not directly translate to 
access to ART and viral suppression. Access to medications is critical to the management of 
HIV infection and achievement of viral suppression. Additional data are needed that will 
specifically address why patients choose a pharmacy and how they access their pharmacy 
(i.e. type of transportation versus mail-order). Answers to these questions, analyzed in 
conjunction with observed travel distances, may better explain patients’ care seeking 
behavior and help determine future interventions.
Our study is limited in that data are derived from a relatively small number of PLWH linked 
to care within a single city with a high prevalence of HIV infection and economic 
deprivation. Thus, our findings may not generalize to other cities. Also, we used HIV 
surveillance dataset; as such we could not assess ART coverage, may have incompletely 
accounted for migration out of Philadelphia among the patients in the cohort, and used 
laboratory data as a proxy for medical visits. In addition, not all persons diagnosed with HIV 
during 2008 and 2009 would have been eligible for ART based on national treatment 
guidelines. This may explain the lower-than-expected viral suppression rate. To evaluate 
community factors (economic deprivation, treatment and pharmacy accessibility) we created 
indices that have not been widely tested for validity or reliability in this population. While 
we used reasonable strategies for assigning values to geographic areas, these indices need to 
demonstrate utility in additional analyses. Similarly, because we used existing data to 
describe personal characteristics at the time of diagnosis, we were unable to account for 
many important behavioral characteristics and their change over time. While this is an 
important limitation, our interest was in determining the value of existing data in 
understanding barriers to care and informing interventions. Finally, we were unable to 
account for changes in residence over time. This may reduce the precision of our 
associations between community-level factors and residence in hotspots for poor retention in 
care and poor viral suppression.
The analyses reported here represent a new approach to understanding individual and 
community-level barriers to retention in HIV care and viral suppression. Our findings 
suggest that geographically targeted interventions may be warranted and that different 
strategies will be needed to address the various steps along the HIV care continuum. Further 
research is needed to identify variables that describe salient community characteristics, 
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improve the precision of measurement, and guide the development of content for 
interventions to improve retention in care and viral suppression.
Acknowledgments
Source of Funding:
Supported in part by a cooperative agreement with the Centers for Disease Control and Prevention (PS13-130202, 
#U62/003959). Preparation of this manuscript was supported in part by the following grants: P30-AI-45008, P30-
AI-087714, K23-MH097647;. The sponsors had no involvement in the research or resulting publication.
BRY has provided consultancy to and received grants to his institution from Gilead Sciences. KAB participates in 
the Speaker’s Bureau for Gilead Sciences and received grants to her institution from Gilead Science.
REFERENCES
1. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV 
care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical infectious 
diseases : an official publication of the Infectious Diseases Society of America. 2011 Mar 15; 52(6):
793–800. [PubMed: 21367734] 
2. Eberhart MG, Yehia BR, Hillier A, et al. Behind the Cascade: Analyzing Spatial Patterns Along the 
HIV Care Continuum. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2013 Nov.
64:S42–S51.
3. Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement 
in care and viral suppression for HIV-infected injection drug users. Aids. 2013 Oct 23; 27(16):
2559–2566. [PubMed: 23770493] 
4. Koblin BA, Andrasik M, Austin J. Preparing for the unexpected: the pivotal role of social and 
behavioral sciences in trials of biomedical HIV prevention interventions. Journal of acquired 
immune deficiency syndromes. 2013 Jul; 63(Suppl 2):S183–S186. [PubMed: 23764634] 
5. Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-
infected patients receiving antiretroviral therapy. Jama. 2012 Jul 25; 308(4):339–342. [PubMed: 
22820781] 
6. Yehia BR, Kangovi S, Frank I. Patients in transition: avoiding detours on the road to HIV treatment 
success. Aids. 2013 Jun 19; 27(10):1529–1533. [PubMed: 23435297] 
7. Yehia BR, Schranz AJ, Momplaisir F, et al. Outcomes of HIV-infected patients receiving care at 
multiple clinics. AIDS and behavior. 2014 Aug; 18(8):1511–1522. [PubMed: 24077931] 
8. Yehia BR, French B, Fleishman JA, et al. Retention in care is more strongly associated with viral 
suppression in HIV-infected patients with lower versus higher CD4 counts. Journal of acquired 
immune deficiency syndromes. 2014 Mar 1; 65(3):333–339. [PubMed: 24129370] 
9. Yehia BR, Ketner E, Momplaisir F, et al. Location of HIV Diagnosis Impacts Linkage to Medical 
Care. Journal of acquired immune deficiency syndromes. 2014 Dec 2.
10. Yehia BR, Rebeiro P, Althoff KN, et al. The Impact of Age on Retention in Care and Viral 
Suppression. Journal of acquired immune deficiency syndromes. 2014 Dec 31.
11. Hall HI, Tang T, Westfall AO, Mugavero MJ. HIV care visits and time to viral suppression, 19 
U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy. 
PloS one. 2013; 8(12):e84318. [PubMed: 24391937] 
12. Gardner EM, Young B. The HIV care cascade through time. The Lancet infectious diseases. 2014 
Jan; 14(1):5–6. [PubMed: 24076276] 
13. Mahle Gray K, Tang T, Shouse L, Li J, Mermin J, Hall HI. Using the HIV surveillance system to 
monitor the National HIV/AIDS Strategy. American journal of public health. 2013 Jan; 103(1):
141–147. [PubMed: 23153150] 
14. Crawford TN, Sanderson WT, Thornton A. Impact of poor retention in HIV medical care on time 
to viral load suppression. Journal of the International Association of Providers of AIDS Care. 2014 
May-Jun;13(3):242–249. [PubMed: 23761217] 
Eberhart et al. Page 9
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
15. Eberhart MG, Yehia BR, Hillier A, et al. Behind the Cascade: Analyzing Spatial Patterns Along 
the HIV Care Continuum. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013; 
64:S42–S51. [PubMed: 24126447] 
16. Underwood C, Hendrickson Z, Van Lith LM, Lengwe Kunda JE, Mallalieu EC. Role of 
community-level factors across the treatment cascade: a critical review. Journal of acquired 
immune deficiency syndromes. 2014 Aug 15; 66(Suppl 3):S311–S318. [PubMed: 25007202] 
17. Beer L, Oster AM, Mattson CL, Skarbinski J. for the Medical Monitoring P. Disparities in HIV 
transmission risk among HIV-infected black and white MSM, Medical Monitoring Project, 2009. 
Aids. 2013 Aug 12.
18. Rourke SB, Bekele T, Tucker R, et al. Housing characteristics and their influence on health-related 
quality of life in persons living with HIV in Ontario, Canada: results from the positive spaces, 
healthy places study. AIDS and behavior. 2012 Nov; 16(8):2361–2373. [PubMed: 22903401] 
19. Bauman LJ, Braunstein S, Calderon Y, et al. Barriers and facilitators of linkage to HIV primary 
care in New York City. Journal of acquired immune deficiency syndromes. 2013 Nov 1; 64(Suppl 
1):S20–S26. [PubMed: 24126445] 
20. Heckman TG, Somlai AM, Peters J, et al. Barriers to care among persons living with HIV/AIDS in 
urban and rural areas. AIDS care. 1998; 10(3):365–375. [PubMed: 9828979] 
21. Whitman S, Silva A, Shah A, Ansell D. Diversity and disparity: GIS and small-area analysis in six 
Chicago neighborhoods. Journal of medical systems. 2004; 28(4):397–411. [PubMed: 15366244] 
22. Continelli T, McGinnis S, Holmes T. The effect of local primary care physician supply on the 
utilization of preventive health services in the United States. Health & place. 2010; 16(5):942–951. 
[PubMed: 20691391] 
23. Keesee MS, Natale AP, Curiel HF. HIV positive Hispanic/Latinos who delay HIV care: analysis of 
multilevel care engagement barriers. Social work in health care. 2012; 51(5):457–478. [PubMed: 
22583031] 
24. Forum NQ. Medical Visit Frequency. 2013 http://www.qualityforum.org/Home.aspx. 
25. Rebeiro P, Althoff KN, Buchacz K, et al. Retention among North American HIV-infected persons 
in clinical care, 2000–2008. Journal of acquired immune deficiency syndromes. 2013 Mar 1; 
62(3):356–362. [PubMed: 23242158] 
26. ArcGIS - ArcToolbox - Add GTFS to Network Dataset [computer program]. Version 10.1. 
Redlands, CA: Morang, Melinda & Stevens, Patrick; ESRI; 
27. Horberg, MHL.; Towner, W.; Gambatese, R.; Klein, D.; Antoniskis, D.; Kadlecik, P.; Kovach, D.; 
Remmers, C.; Silverberg, M. HIV spectrum of engagement cascade in a large integrated care 
system by gender, age, methodologies. 20th Conference on Retroviruses and Opportunistic 
Infections; March 3–6, 2013; Atlanta, GA. 2013. 
28. Baligh, R.; Yehia, AJS.; Agwu, Allison L.; Berry, Stephen A.; Metlay, Joshua P.; Gebo, Kelly A. 
The HIV Treatment Cascade: Is There More to the Story?. 21st Conference on Retroviruses and 
Opportunistic Infections; March 3–6, 2014; Boston. 2014. 
29. Vaughan AS, Rosenberg E, Shouse RL, Sullivan PS. Connecting race and place: a county-level 
analysis of White, Black, and Hispanic HIV prevalence, poverty, and level of urbanization. 
American journal of public health. 2014 Jul; 104(7):e77–e84. [PubMed: 24832420] 
30. Shacham E, Lian M, Onen NF, Donovan M, Overton ET. Are neighborhood conditions associated 
with HIV management? HIV medicine. 2013 Nov; 14(10):624–632. [PubMed: 23890194] 
31. Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection 
among women living in the United States. Current HIV/AIDS reports. 2007 Dec; 4(4):181–186. 
[PubMed: 18366949] 
32. McMahon J, Wanke C, Terrin N, Skinner S, Knox T. Poverty, hunger, education, and residential 
status impact survival in HIV. AIDS and behavior. 2011 Oct; 15(7):1503–1511. [PubMed: 
20632079] 
33. Kalichman SC, Grebler T. Stress and poverty predictors of treatment adherence among people with 
low-literacy living with HIV/AIDS. Psychosomatic medicine. 2010 Oct; 72(8):810–816. [PubMed: 
20716711] 
34. Kalichman SC, Hernandez D, Cherry C, Kalichman MO, Washington C, Grebler T. Food 
insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment 
Eberhart et al. Page 10
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
and health outcomes. Journal of community health. 2014 Dec; 39(6):1133–1139. [PubMed: 
24705680] 
35. Oldenburg CE, Perez-Brumer AG, Reisner SL. Poverty matters: contextualizing the syndemic 
condition of psychological factors and newly diagnosed HIV infection in the United States. Aids. 
2014 Nov 28; 28(18):2763–2769. [PubMed: 25418633] 
36. Cescon A, Patterson S, Chan K, et al. Gender differences in clinical outcomes among HIV-positive 
individuals on antiretroviral therapy in Canada: a multisite cohort study. PloS one. 2013; 
8(12):e83649. [PubMed: 24391803] 
37. Hanna DB, Hessol NA, Golub ET, et al. Increase in single-tablet regimen use and associated 
improvements in adherence-related outcomes in HIV-infected women. Journal of acquired 
immune deficiency syndromes. 2014 Apr 15; 65(5):587–596. [PubMed: 24326606] 
38. McFall AM, Dowdy DW, Zelaya CE, et al. Understanding the disparity: predictors of virologic 
failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. Journal 
of acquired immune deficiency syndromes. 2013 Nov 1; 64(3):289–298. [PubMed: 23797695] 
39. Eberhart MG, Voytek CD, Hillier A, Metzger DS, Blank MB, Brady KA. Travel Distance to HIV 
Medical Care: A Geographic Analysis of Weighted Survey Data from the Medical Monitoring 
Project in Philadelphia, PA. AIDS and behavior. 2014 Apr; 18(4):776–782. [PubMed: 24141487] 
40. Amstislavski P, Matthews A, Sheffield S, Maroko AR, Weedon J. Medication deserts: survey of 
neighborhood disparities in availability of prescription medications. Int J Health Geogr. 2012 Nov 
9.:11. [PubMed: 22537116] 
Eberhart et al. Page 11
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
FIGURE 1. 
Hotspots for poor HIV treatment retention and viral supression among individuals diagnosed 
in 2008 and 2009
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